Your browser doesn't support javascript.
loading
Pharmaceutical industry funding and chemotherapy trials for prostate cancer: A systematic review.
Heydari, Amirreza; Shakiba, Behnam; Moradi, Asaad; Soofian, Saeed Esmaeil; Abian, Nasrollah; Heidari, Kazem; Maghsoudi, Robab.
Afiliação
  • Heydari A; School of medicine, Iran university of medical sciences, Tehran, Iran.
  • Shakiba B; Department of Urology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences; Firoozgar Clinical Research Development Center, Iran University of Medical Sciences. Electronic address: shakiba.b@iums.ac.ir.
  • Moradi A; Department of Urology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences.
  • Soofian SE; Hasheminejad Kidney Center, School of medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Abian N; Azar Hospital, Golestan University of Medical Sciences and Health Servicess, Gorgan, Iran.
  • Heidari K; Clinical Trial Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Maghsoudi R; Department of Urology, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences.
Cancer Treat Res Commun ; 36: 100739, 2023.
Article em En | MEDLINE | ID: mdl-37419057
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Indústria Farmacêutica Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Indústria Farmacêutica Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Cancer Treat Res Commun Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã